Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis

Overview of attention for article published in Archives of Endocrinology and Metabolism, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#34 of 801)
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

twitter: 4 X users

Readers on

mendeley: 42 Mendeley

Summary Blogs Policy documents X

So far, Altmetric has seen 1 policy document that references this research output.

Sodium-Glucose Cotransporter-2 Inhibitors for Type 2 Diabetes Mellitus

Cited by Canadian Agency for Drugs and Technologies in Health on 28 Sep 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.